Clinical Trial Update: Follow on Study From RE-ALIGN [Phase 2]

View source ↗

Summary

A Phase 2 follow-on study from RE-ALIGN evaluating dabigatran in patients with thromboembolism and prosthetic heart valves was terminated; results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboembolism
• Valvular Heart Disease

Drugs mentioned

• Pradaxa (dabigatran etexilate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Thromboembolism, Heart Valve Prosthesis | Phase 2 | Status: TERMINATED | Results posted: 2014-07-11